A Closer Look at Insulin Resistance in Pulmonary Arterial Hypertension

Gustavo Heresi, MD, MS, Director of the Pulmonary Vascular and Chronic Thromboembolic Pulmonary Hypertension Program, led a new study that challenges the prevailing literature on insulin resistance in individuals with pulmonary arterial hypertension. These findings highlight the importance of metabolic research in PAH and may promote new lines of scientific inquiry, including both pharmacological and dietary approaches, for the treatment of PAH.

Advertising Policy

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy

Advertising Policy